Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Benjamin

Showing results (321-330 of 335) with videos related to

Pageof 34
Sort By:
Journal of Clinical Pharmacology|December 3, 2014
Assessment of the drug interaction potential and single- and repeat-dose pharmacokinetics of the BRAF inhibitor dabrafenibA Benjamin Suttle, Kenneth F Grossmann, Daniele Ouellet, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 8, 2016
Arterial ischemic stroke in HIV: Defining and classifying etiology for research studiesLaura A Benjamin, Alan Bryer, Sebastian Lucas, et al.
Brain Communications|July 11, 2022
Vessel wall magnetic resonance and arterial spin labelling imaging in the management of presumed inflammatory intracranial arterial vasculopathyL A Benjamin, E Lim, M Sokolska, et al.
Journal of Neurochemistry|February 9, 2022
Amyloid processing in COVID-19-associated neurological syndromesOliver J Ziff, Nicholas J Ashton, Puja R Mehta, et al.
AIDS (London, England)|December 11, 2020
Benefits of enhanced infection prophylaxis at antiretroviral therapy initiation by cryptococcal antigen statusSarah L Pett, Moira Spyer, Lewis J Haddow, et al.
Clinical Medicine (London, England)|April 20, 2024
Addressing ethnic disparities in neurological research in the United Kingdom: An example from the prospective multicentre COVID-19 Clinical Neuroscience StudyDaniel J van Wamelen, Silvia Rota, Monika Hartmann, et al.
Blood|May 5, 2018
The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemiaEytan M Stein, Guillermo Garcia-Manero, David A Rizzieri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 9, 2013
Phase I study of pazopanib in patients with advanced solid tumors and hepatic dysfunction: a National Cancer Institute Organ Dysfunction Working Group studyStephen I Shibata, Vincent Chung, Timothy W Synold, et al.
The Lancet. Psychiatry|June 29, 2020
Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance studyAravinthan Varatharaj, Naomi Thomas, Mark A Ellul, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 5, 2020
Individual-specific functional connectivity of the amygdala: A substrate for precision psychiatryChad M Sylvester, Qiongru Yu, A Benjamin Srivastava, et al.
Pageof 34

Showing results (321-330 of 335) with videos related to

Sort By:
Pageof 34
Journal of Clinical Pharmacology|December 3, 2014
Assessment of the drug interaction potential and single- and repeat-dose pharmacokinetics of the BRAF inhibitor dabrafenibA Benjamin Suttle, Kenneth F Grossmann, Daniele Ouellet, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 8, 2016
Arterial ischemic stroke in HIV: Defining and classifying etiology for research studiesLaura A Benjamin, Alan Bryer, Sebastian Lucas, et al.
Brain Communications|July 11, 2022
Vessel wall magnetic resonance and arterial spin labelling imaging in the management of presumed inflammatory intracranial arterial vasculopathyL A Benjamin, E Lim, M Sokolska, et al.
Journal of Neurochemistry|February 9, 2022
Amyloid processing in COVID-19-associated neurological syndromesOliver J Ziff, Nicholas J Ashton, Puja R Mehta, et al.
AIDS (London, England)|December 11, 2020
Benefits of enhanced infection prophylaxis at antiretroviral therapy initiation by cryptococcal antigen statusSarah L Pett, Moira Spyer, Lewis J Haddow, et al.
Clinical Medicine (London, England)|April 20, 2024
Addressing ethnic disparities in neurological research in the United Kingdom: An example from the prospective multicentre COVID-19 Clinical Neuroscience StudyDaniel J van Wamelen, Silvia Rota, Monika Hartmann, et al.
Blood|May 5, 2018
The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemiaEytan M Stein, Guillermo Garcia-Manero, David A Rizzieri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 9, 2013
Phase I study of pazopanib in patients with advanced solid tumors and hepatic dysfunction: a National Cancer Institute Organ Dysfunction Working Group studyStephen I Shibata, Vincent Chung, Timothy W Synold, et al.
The Lancet. Psychiatry|June 29, 2020
Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance studyAravinthan Varatharaj, Naomi Thomas, Mark A Ellul, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 5, 2020
Individual-specific functional connectivity of the amygdala: A substrate for precision psychiatryChad M Sylvester, Qiongru Yu, A Benjamin Srivastava, et al.
Pageof 34